If you've done 23andMe and looked at your health reports, there's a good chance you've seen something about MTHFR. Maybe it flagged a variant and mentioned a connection to folate. Maybe you searched "MTHFR 23andMe" and landed in a corner of the internet that's either dismissive ("it's not a big deal") or alarmist ("it causes everything"). Neither extreme is helpful.

The real issue isn't just that MTHFR is confusing — it's that 23andMe shows you one piece of a much larger system and gives you almost no context for what to do with it. To understand what your results actually mean, you need to understand the methylation cycle as a whole: what it does, which genes are involved, how they interact, and why the status of one gene doesn't tell you much without knowing the others.

This article is that guide.

What Methylation Actually Is

Methylation is a chemical reaction. Specifically, it's the transfer of a methyl group — one carbon atom bonded to three hydrogen atoms (CH₃) — onto another molecule. That sounds technical, but the significance is enormous: this reaction happens billions of times per second in every cell in your body, and it controls some of the most fundamental processes in human biology.[6]

When a methyl group is added to a strand of DNA, it acts like a dimmer switch — silencing or activating specific genes without changing the underlying sequence. This is the field of epigenetics, and methylation is one of its primary mechanisms. When methyl groups are added to neurotransmitters like dopamine and serotonin, those molecules are broken down and cleared. When they're added during the synthesis of creatine, phospholipids, or myelin, new molecules are built.[1] Methylation is the backbone of detoxification, immune regulation, inflammation control, and energy metabolism.

A system this central to human health doesn't have a single on/off switch. It's a cycle — a continuous loop of reactions that regenerates the methyl donors your body needs to keep everything running. And like any cycle, a problem at any point can ripple through the whole thing.

The Methylation Cycle in Plain English

The core of the methylation cycle involves a molecule called SAMe (S-adenosylmethionine). SAMe is your body's primary methyl donor — it's the molecule that actually hands off methyl groups to the hundreds of reactions that need them.[14] Every time SAMe donates a methyl group, it becomes SAH (S-adenosylhomocysteine), which then breaks down into homocysteine.

Homocysteine is the crossroads of the cycle. At this point, one of two things needs to happen: homocysteine either gets converted back into methionine (which then gets recharged into SAMe and keeps the cycle going), or it gets shunted down a different pathway called the transsulfuration pathway, which produces glutathione — your body's master antioxidant.

Converting homocysteine back to methionine requires B12 and folate. Specifically, it requires methylfolate (the active form of folate) and methylcobalamin (the active form of B12). The enzyme that handles this conversion is methionine synthase, coded by the MTR gene. The enzyme that keeps MTR functional by regenerating its B12 cofactor is methionine synthase reductase, coded by the MTRR gene.[5]

Where does methylfolate come from? It's produced from folate by the enzyme MTHFR — which is where your 23andMe result enters the picture.[2] MTHFR converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate (5-MTHF), the active form that feeds directly into the MTR reaction.

So the simplified flow looks like this: dietary folate → methylfolate (via MTHFR) → feeds into MTR/MTRR → homocysteine → methionine → SAMe → methylation reactions → homocysteine → repeat. Each step depends on the one before it. A slowdown anywhere creates a bottleneck.[7]

The Key Methylation Genes in Your 23andMe Raw Data

This is where things get specific — and where 23andMe's health report falls short. The report shows you one variant (MTHFR C677T, more on this below) but your raw data file contains SNPs across all the major methylation genes. Here's what each one does:

MTHFR — The Most Famous, Not the Only One

The MTHFR gene has two clinically significant variants that 23andMe captures in the raw data: C677T (rs1801133) and A1298C (rs1801131).

C677T is the more studied of the two. Carrying one copy (heterozygous) reduces MTHFR enzyme activity by roughly 35%. Carrying two copies (homozygous, written as TT) reduces it by around 70%.[2] This directly limits how much methylfolate your body can produce from dietary folate or supplemental folic acid.

A1298C has a more modest effect on its own, but the interaction between the two variants matters.[3] Being compound heterozygous — one copy of C677T and one copy of A1298C — produces a meaningful reduction in enzyme activity that neither variant causes alone.[12] This is why you can't evaluate MTHFR by looking at one SNP in isolation.

23andMe's health report only mentions C677T. A1298C is in the raw data but absent from the consumer-facing report.

MTR — The Engine That Uses Methylfolate

MTR codes for methionine synthase, the enzyme that uses methylfolate and B12 together to convert homocysteine back into methionine. The key variant here is A2756G (rs1805087). Carrying the G allele is associated with altered B12 binding, which can impair the conversion reaction — particularly when B12 status is borderline.[11]

This means that even if your MTHFR is functioning normally and producing plenty of methylfolate, a variant in MTR can create a bottleneck further downstream. The methylfolate is available but can't be used effectively.

MTRR — The Maintenance Enzyme for MTR

MTR's B12 cofactor gradually gets oxidized and inactivated during normal function. MTRR (methionine synthase reductase) is the enzyme that reactivates it by reducing it back to its functional state. The key variant is A66G (rs1801394).[4]

MTRR A66G is one of the most common functional variants in the methylation pathway. When MTRR activity is reduced, the MTR enzyme gradually loses function even when dietary B12 intake is adequate — because the problem isn't getting B12 in, it's keeping it active once it's there.[13] MTR and MTRR need to be read together: a person with variants in both has a compounded B12 recycling problem that neither variant predicts alone.

COMT — Where Methylation and Neurotransmitters Intersect

COMT (catechol-O-methyltransferase) uses SAMe to break down catecholamines — dopamine, epinephrine, norepinephrine, and estrogen metabolites. The well-studied variant is Val158Met (rs4680), sometimes written as the G or A allele.[8]

The Met allele (A) reduces COMT enzyme activity by about 40%. People with this variant break down dopamine more slowly, which can affect mood, stress response, and focus. But COMT's role in methylation analysis is often misunderstood: it's a major consumer of SAMe. If your methylation cycle is under-producing SAMe due to MTHFR or MTR issues, COMT's demand on that limited supply becomes more significant. Conversely, aggressive methylation supplementation in someone with slow COMT can overshoot and create too much catecholamine clearance, causing irritability or anxiety.

This is one of several reasons why supplementing based on MTHFR status alone, without knowing COMT, can produce unexpected results.

AHCY — The Brake on the Cycle

AHCY codes for adenosylhomocysteinase, the enzyme that breaks down SAH into homocysteine. This step sounds minor, but if AHCY runs slowly, SAH builds up — and elevated SAH directly inhibits the methyltransferase reactions that SAMe is trying to drive.[14] In other words, a sluggish AHCY gene can cause methylation to grind to a halt even when SAMe levels look normal. Several SNPs in AHCY are captured in 23andMe raw data and are meaningful when interpreting the full cycle.

BHMT — The Shortcut Route

BHMT (betaine-homocysteine methyltransferase) provides an alternative pathway for converting homocysteine back to methionine — one that uses betaine (trimethylglycine) instead of folate and B12.[11] This pathway is primarily active in the liver and kidneys, but it's an important backup when the MTR/MTRR pathway is compromised.

BHMT variants affect how efficiently this backup route runs. For people with significant MTR or MTRR variants, BHMT function becomes especially relevant — it determines how much of the shortfall can be compensated by betaine rather than by pushing more B12 and methylfolate into a struggling system.

Homocysteine: The Blood Marker That Ties It Together

If the methylation cycle is running poorly, homocysteine accumulates. This isn't just a theoretical concern — elevated homocysteine is a well-established risk factor for cardiovascular disease, stroke, cognitive decline, and pregnancy complications.[9] It's also the most practical way to assess methylation status in a clinical context.

Optimal homocysteine is generally considered to be below 7–9 µmol/L. Levels above 15 µmol/L are classified as hyperhomocysteinemia.[10] Most standard lab panels include it, though many physicians only flag it when it's severely elevated.

Here's the important nuance: homocysteine tells you that the cycle is struggling, but your genetics tell you why. Someone with MTHFR C677T homozygous, MTR A2756G, and MTRR A66G all present together has a very different mechanism of elevated homocysteine than someone whose elevation is diet-driven or due to B12 deficiency alone. The intervention — which supplements, in what forms, at what doses — differs accordingly. A genetic analysis gives you the map. Homocysteine testing tells you whether the map is relevant to your current situation.

Undermethylation vs. Overmethylation

In functional and integrative medicine, clinicians often describe patients as being in an undermethylated or overmethylated state. These are useful clinical categories, though they're better understood as tendencies rather than binary diagnoses.

Signs associated with undermethylation include depression, OCD tendencies, perfectionism, competitive drive, low serotonin symptoms, high histamine sensitivity, and strong response to antihistamines. Biochemically, these individuals often have low SAMe relative to SAH, and their methylation cycle is producing less methyl capacity than demand requires.

Signs associated with overmethylation — which is less common and often iatrogenic (caused by aggressive supplementation) — include anxiety, paranoia, hyperactivity, low motivation, high copper relative to zinc, and sensitivities to methylated supplements like methylfolate or methylcobalamin. Some people react badly to methylfolate supplements not because the gene is fine, but because additional methyl groups push COMT activity in a direction that depletes dopamine too aggressively.

This is why blanket recommendations to "take methylfolate if you have MTHFR" are an oversimplification. The right approach accounts for COMT status, current homocysteine levels, and the full pattern of variants across the cycle — not a single gene.

What 23andMe Shows You — and What It Doesn't

23andMe's health reports are designed for a general audience. They're conservative, legally cautious, and deliberately simplified. For methylation, the consumer report does one thing: it tells you whether you carry the MTHFR C677T variant (rs1801133) and categorizes your status as typical or variant. That's it.

It does not report A1298C. It does not mention MTR, MTRR, COMT, AHCY, or BHMT. It does not explain what any of these variants mean in combination. It does not recommend any specific supplements or forms. It suggests you talk to a doctor — which is reasonable advice, but most physicians haven't been trained in methylation genetics and have no protocol to offer.

Your raw data file tells a very different story. Every SNP discussed in this article — all of the MTHFR variants, MTR A2756G, MTRR A66G, COMT Val158Met, AHCY variants, BHMT variants — is present in the raw data file that 23andMe lets you download. The information is there. The consumer report just doesn't surface it.

This is the gap that exists between having a 23andMe result and actually understanding what your methylation genetics mean for your health and your supplement protocol.

What a Comprehensive Methylation Analysis Looks Like

A proper methylation analysis starts with the raw data and works through the cycle systematically. It looks at each gene's variants individually, then models how they interact. A person with MTHFR C677T homozygous and functional MTR/MTRR has a different problem than someone whose MTHFR is fine but whose MTRR is significantly impaired. Both might present with elevated homocysteine, but the first person needs methylfolate optimization and the second needs a focus on B12 recycling.

A complete analysis also accounts for COMT before recommending methyl donors — because aggressive methylfolate supplementation in a slow-COMT individual can cause overstimulation, anxiety, or irritability. It considers BHMT as a potential supporting pathway. It looks at AHCY to identify whether SAH clearance is a limiting factor. And it translates all of this into specific recommendations: which forms of folate and B12 to use, what doses make sense given the variant load, whether betaine or choline are relevant supporting nutrients, and what blood markers to track to confirm the protocol is working.

This is what Whole Gene Health's methylation report delivers. Not a list of your variants with a suggestion to "consult a healthcare provider." A complete, actionable protocol built from your actual raw data — covering every gene in the cycle, the interactions between them, specific supplement recommendations with forms and dosages, and the blood markers you should monitor to verify it's working.

Your 23andMe data already contains everything needed to build this analysis. The work is in knowing what to do with it.